# US 2013/0156861 A1 · Alcoholic injury mitigating agent

> Agents: this data is available as JSON from the patentgrep API and MCP server — see https://patentgrep.com/llms.txt

- Number: US 2013/0156861 A1
- Document ID: US20130156861A1
- Status: Published application
- Kind: A1
- Application number: 13/820,170
- Filed: 2011-09-01
- Published: 2013-06-20
- Earliest claimed: 2010-09-01
- Assignees: Nippon Suisan Kaisha, Ltd.
- Inventors: Junichiro Hata; Tomoko Tsuji; Kenichi Yanagimoto
- Web page: https://patentgrep.com/patent/US20130156861A1

## CPC

- A61K 35/612: Crustaceans, e.g. crabs, lobsters, shrimps, krill or crayfish; Barnacles
- A23L 2/52: Adding ingredients (adding preservatives A23B70/10)
- A23L 33/115: Fatty acids or derivatives thereof; Fats or oils
- A61K 31/202: having three or more double bonds, e.g. linolenic (eicosanoids, e.g. leukotrienes A61K31/557)
- A61P 1/16: for liver or gallbladder disorders, e.g. hepatoprotective agents, cholagogues, litholytics
- A61P 3/00: Drugs for disorders of the metabolism (of the blood or the extracellular fluid A61P7/00)
- A61P 19/06: Antigout agents, e.g. antihyperuricemic or uricosuric agents
- A61P 43/00: Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
- A61K: PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES (devices or methods specially adapted for bringing pharmaceutical products into particular physical or administering forms A61J3/00; chemical aspects of, or use of materials for deodorisation of air, for disinfection or sterilisation, or for bandages, dressings, absorbent pads or surgical articles A61L; soap compositions C11D)
- A23L: FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF (preservation thereof A23B)
- A61P: SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS

## Abstract

The present invention relates to an alcoholic injury mitigating agent comprising krill oil as an active ingredient. The krill oil preferably comprises phospholipids in an amount of at least 30% by weight, ω3 polyunsaturated fatty acids in an amount of at least 5% by weight of the total fatty acids, eicosapentaenoic acid in an amount of at least 2% by weight of the total fatty acids, or docosahexaenoic acid in an amount of at least 1% by weight of the total fatty acids.

## Claims

### Claim 1

A method for mitigating alcoholic injury, comprising administering an effective amount of krill oil to a subject.

### Claim 2 (depends on 1)

A method according to claim 1, for use in suppression of an increase in blood ethanol concentration, mitigation of a symptom of drunkenness, promotion of recovery from the symptoms of drunkenness, suppression of liver injury, suppression of dehydration, or suppression of an increase in blood glucose level.

### Claim 3 (depends on 1)

A method according to claim 1, wherein the mitigation of alcoholic injury is based on inhibition of alcohol absorption and/or promotion of alcohol metabolism, each induced by the krill oil.

### Claim 4 (depends on 1)

A method according to claim 1, wherein the krill oil comprises phospholipids in an amount of at least 25% by weight.

### Claim 5 (depends on 1)

A method according to claim 1, wherein at least 5% by weight of the total fatty acids in the krill oil is ω3 polyunsaturated fatty acids.

### Claim 6 (depends on 1)

A method according to claim 1, wherein at least 2% by weight of the total fatty acids in the krill oil is eicosapentaenoic acid.

### Claim 7 (depends on 1)

A method according to claim 1, wherein at least 1% by weight of the total fatty acids in the krill oil is docosahexaenoic acid.

### Claim 8 (depends on 1)

A method according to claim 1, wherein the daily consumption amount of the krill oil is in the range of 1 to 20000 mg.

### Claim 9 (depends on 1)

A method according to claim 1, wherein the krill oil is administered as a food or beverage.

### Claim 10 (depends on 9)

A method according to claim 9, wherein the krill oil is ingested-administered in an amount of 1-20000 mg per a single dose.
